Early data on Gilead coronavirus medicine remdesivir is very encouraging -

  • The University of Chicago Medicine recruited 125 people with Covid-19
  • two Phase 3 clinical trials
  • 113 had severe disease
  • All the patients been treated with daily infusions of remdesivir
  • "The best news is that most of our patients have already been discharged, which is great. We've only had two patients perish," said Kathleen Mullane, the University of Chicago infectious disease specialist overseeing the remdesivir studies for the hospital.
Just if you ask yourself what the rally in S&P Globex is all about....
Yes I saw it DOW 705 !!!
 
  • The University of Chicago Medicine recruited 125 people with Covid-19
  • two Phase 3 clinical trials
  • 113 had severe disease
  • All the patients been treated with daily infusions of remdesivir
  • "The best news is that most of our patients have already been discharged, which is great. We've only had two patients perish," said Kathleen Mullane, the University of Chicago infectious disease specialist overseeing the remdesivir studies for the hospital.
Just if you ask yourself what the rally in S&P Globex is all about....
  • The University of Chicago Medicine recruited 125 people with Covid-19
  • two Phase 3 clinical trials
  • 113 had severe disease
  • All the patients been treated with daily infusions of remdesivir
  • "The best news is that most of our patients have already been discharged, which is great. We've only had two patients perish," said Kathleen Mullane, the University of Chicago infectious disease specialist overseeing the remdesivir studies for the hospital.
Just if you ask yourself what the rally in S&P Globex is all about....
Almost most stocks up... wow
A few days ago a have a filling do not make any shorts ... risky
Check in my history
 
  • The University of Chicago Medicine recruited 125 people with Covid-19
  • two Phase 3 clinical trials
  • 113 had severe disease
  • All the patients been treated with daily infusions of remdesivir
  • "The best news is that most of our patients have already been discharged, which is great. We've only had two patients perish," said Kathleen Mullane, the University of Chicago infectious disease specialist overseeing the remdesivir studies for the hospital.
Just if you ask yourself what the rally in S&P Globex is all about....
Yes I saw it DOW 705 !!!
Can you believe 111 severe people got their life back this is priceless!!! Wow
 
Yeah this may rally markets, so I stopped out of most of my inverses aftermarket and bought small SPXL GILD in case they gap up tomorrow.

I was bearish til cv med announced, will scale back into inverses if they take out 2day highs, for now the bulls are back so I'll join in.

The news is the first meaningful bullish recent data beyond fed that can slow the selling, so I'll hedge. It'll be interesting to see which sectors move the most :p
 
Last edited:
I guess the question is this something Joe Blow can take themselves and what’s what’s the timeline like.

I don’t believe the issue was ever survival rate, it was the strain on health care system. If everyone still has to go to hospital to get treated for a few days the beds still aren’t there.
 
Well we should see DOW will get 24k and most important holds its level for a wile. Stay out of bearish 23655 territory. SP500 should strike up from 2800. And see what happened. I was buying from 3/23 and sick and tired to cover my positions. Let’s get bullish!
.
 
Phase 3 being Last Phase hopefully or still need a bigger study ??

Another 2 Tril pay out, there money printing machine must be on overdrive.

Who knows. Everything is fast tracked now. Here is a generic diagram:
 

Attachments

  • Phases.png
    Phases.png
    233.1 KB · Views: 24
Back
Top